Back to top

Image: Shutterstock

Zacks Market Edge Highlights: Microsoft, Walmart, Chevron, Teladoc Health and AMN Healthcare Services

Read MoreHide Full Article

For Immediate Release

Chicago, IL – April 16, 2020 – Zacks Market Edge is a podcast hosted weekly by cks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:

5 Stocks to Navigate the Coronavirus Earnings Season

Welcome to Episode #221 of the Zacks Market Edge Podcast.

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.

This week, Tracey is joined by Sheraz Mian, Zacks Director of Research, to discuss what the outlook is for the first quarter earnings season and the rest of the year.

Current Zacks data now projects S&P 500 first quarter earnings to fall 11.8%, but that will change daily as more earnings reports roll in.

The second quarter is now expected to decline 19.7%.

The full year 2020 Zacks Consensus is also on the decline, now falling 10.5% after falling just 4.4% by Apr 1. The analysts are getting more aggressive with their second quarter earnings cuts now.

Where Should Investors Be Looking for Safety?

Big caps, especially in technology and in supermarkets and food, have been holding up well in the coronavirus crisis and have the balance sheets to weather the storm in 2020.

That means companies like Microsoft (MSFT - Free Report) and Walmart (WMT - Free Report) should continue to perform well.

Neither stock is much of a “deal” here though.

Microsoft trades with a forward P/E of 29 and Walmart with a forward P/E of 24.

Where Are the Deals?

Energy is expected to see the largest second quarter earnings decline, with the consensus showing a decline of 100%.

Even with crude still at depressed levels, production is now being cut globally.

Should investors be looking at some of the “best” names in the space?

One of the energy companies to consider is Chevron (CVX - Free Report) with its diverse business model, including refining.

However, currently, it’s a Zacks Rank #5 (Strong Sell) because analysts have been cutting 2020 earnings estimates.

They now expect Chevron to lose $0.24 versus its 2019 earnings of $6.27.

Shares are still down 29% year-to-date.

Are Medical Services the Place to Invest?

Business services, including medical services, are expected to be one of the sectors that may have earnings growth in the second quarter.

Two companies to watch are:

1.       Teladoc Health Inc. (TDOC - Free Report) , which is up 91.8% year-to-date already, is not exactly a hidden gem. It’s not expected to have positive earnings this year, but it’s a Zacks Rank #2 (Buy) as demand for telehealth services has soared during the coronavirus.  

2.       AMN Healthcare Services (AMN - Free Report) which provides healthcare workplace solutions and staffing, including doctors and nurses. Shares spiked in March and were up 30% year-to-date, but have since come back down to earth and are up just 2.7% year to date. It trades with a forward P/E of 17.5.

What else do you need to know about how to navigate this coronavirus-impacted earnings season?

Tune into this week’s podcast to find out.

[In full disclosure, Tracey owns shares of MSFT and AMZN, mentioned on the podcast, in her personal portfolio.]

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/performance

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.